In many studies, it has been suggested that exposure to IL-21 alone results in lymphocytes that remain in or differentiate into a minimally differentiated phenotype (CD62L+CD44–), and that these lymphocytes have greater anti-tumor capacity relative to cells expanded in other γ chain cytokines [10,27,36]. This evidence concerns the gene CD44 and neoplasm.